Apotex’s India Plants Hit with Expanded Import Ban by Health Canada

Health Canada has expanded its initial import ban on Apotex’s finished product facility in Bangalore, India, to include the generics makers’ raw materials plant in the city, as well as other India manufacturers.
Drug Industry Daily